1. Home
  2. FXNC vs VYGR Comparison

FXNC vs VYGR Comparison

Compare FXNC & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First National Corporation

FXNC

First National Corporation

HOLD

Current Price

$25.70

Market Cap

229.4M

Sector

Finance

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.76

Market Cap

226.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FXNC
VYGR
Founded
1907
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
229.4M
226.8M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
FXNC
VYGR
Price
$25.70
$3.76
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$17.00
AVG Volume (30 Days)
24.1K
522.0K
Earning Date
02-05-2026
11-10-2025
Dividend Yield
2.65%
N/A
EPS Growth
10.94
N/A
EPS
1.24
N/A
Revenue
$81,206,000.00
$31,316,000.00
Revenue This Year
$56.13
N/A
Revenue Next Year
$3.27
$71.78
P/E Ratio
$20.65
N/A
Revenue Growth
66.40
N/A
52 Week Low
$18.26
$2.65
52 Week High
$26.97
$5.96

Technical Indicators

Market Signals
Indicator
FXNC
VYGR
Relative Strength Index (RSI) 60.07 39.01
Support Level $25.00 $3.81
Resistance Level $25.95 $4.24
Average True Range (ATR) 0.50 0.21
MACD -0.00 -0.02
Stochastic Oscillator 83.81 6.73

Price Performance

Historical Comparison
FXNC
VYGR

About FXNC First National Corporation

First National Corp is a bank holding company of First Bank, which is a commercial bank. Its core offering includes loans, deposits, wealth management, and other products and services. The Company operates through two reportable operating segments: Community Banking and wealth management. The Community Banking segment involves making loans and generating deposits from individuals, businesses, and charitable organizations. Wealth Management Services offers corporate trustee services, trust and estate administration, IRA administration and custody services. Key revenue is generated from Community Banking.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: